Literature DB >> 35303998

Emerging concepts of miRNA therapeutics: from cells to clinic.

Caroline Diener1, Andreas Keller2, Eckart Meese1.   

Abstract

MicroRNAs (miRNAs) are very powerful genetic regulators, as evidenced by the fact that a single miRNA can direct entire cellular pathways via interacting with a broad spectrum of target genes. This property renders miRNAs as highly interesting therapeutic tools to restore cell functions that are altered as part of a disease phenotype. However, this strength of miRNAs is also a weakness because their cellular effects are so numerous that off-target effects can hardly be avoided. In this review, we point out the main challenges and the strategies to specifically address the problems that need to be surmounted in the push toward a therapeutic application of miRNAs. Particular emphasis is given to approaches that have already found their way into clinical studies.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  cell functional manipulations; clinical trials; microRNA; preclinical studies; therapeutics

Mesh:

Substances:

Year:  2022        PMID: 35303998     DOI: 10.1016/j.tig.2022.02.006

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  10 in total

Review 1.  Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1.

Authors:  Miguel Angel Martinez; Cristina Tural; Sandra Franco
Journal:  Viruses       Date:  2022-05-24       Impact factor: 5.818

Review 2.  Long Non-Coding RNAs as Potential Regulators of EMT-Related Transcription Factors in Colorectal Cancer-A Systematic Review and Bioinformatics Analysis.

Authors:  Ana Pavlič; Nina Hauptman; Emanuela Boštjančič; Nina Zidar
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

3.  A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.

Authors:  Chiara Gargiuli; Loris De Cecco; Andrea Mariancini; Maria Federica Iannò; Arianna Micali; Elisa Mancinelli; Mattia Boeri; Gabriella Sozzi; Matteo Dugo; Marialuisa Sensi
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

4.  Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene.

Authors:  Chiara Papi; Jessica Gasparello; Matteo Zurlo; Alex Manicardi; Roberto Corradini; Giulio Cabrini; Roberto Gambari; Alessia Finotti
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

Review 5.  Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.

Authors:  Fei Liu; Shenglong Li
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

Review 6.  Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases.

Authors:  Shih-Chun Yang; Ahmed Alalaiwe; Zih-Chan Lin; Yu-Chih Lin; Ibrahim A Aljuffali; Jia-You Fang
Journal:  Biomolecules       Date:  2022-08-03

7.  Flow cytometry-based high-throughput RNAi screening for miRNAs regulating MHC class II HLA-DR surface expression.

Authors:  Maja Houseman; Melody Ying-Yu Huang; Markus Huber; Matthias Staiger; Lan Zhang; Anneliese Hoffmann; Christoph Lippuner; Frank Stüber
Journal:  Eur J Immunol       Date:  2022-06-09       Impact factor: 6.688

8.  Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence.

Authors:  Giovanna Azzarito; Lisa Kurmann; Brigitte Leeners; Raghvendra K Dubey
Journal:  Cells       Date:  2022-09-23       Impact factor: 7.666

9.  Targeting non-coding RNA family members with artificial endonuclease XNAzymes.

Authors:  Maria J Donde; Adam M Rochussen; Saksham Kapoor; Alexander I Taylor
Journal:  Commun Biol       Date:  2022-09-24

Review 10.  miRNA: A Promising Therapeutic Target in Cancer.

Authors:  Amrutha Menon; Noraini Abd-Aziz; Kanwal Khalid; Chit Laa Poh; Rakesh Naidu
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.